Encoded Therapeutics

Translating Next-Generation Science into Transformative Gene Therapies

South San Francisco, United States · Founded 2014 · $239.0M raised

Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$239.0M
Last Round
$135.0M Series DJul 2020
Rounds
3

About

Encoded Therapeutics is a clinical-stage biotech company developing precision genetic medicines for severe pediatric central nervous system disorders, with a lead program targeting SCN1A+ Dravet syndrome. The company's novel targeting and regulation platform enables cell-type-specific gene expression, overcoming limitations of first-generation gene therapies. In January 2026, ETX101 received FDA Breakthrough Therapy Designation for the treatment of Dravet syndrome.

Summary

Encoded Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2014. It has raised $239.0M in total across 3 rounds, most recently a $135.0M Series D round in Jul 2020. Investors include ARCH Venture Partners, Venrock and GV.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series DSeries DJul 2020
$135.0M

Sign up to see all 3 rounds

Seed through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Encoded Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/encoded-therapeutics"><img src="https://indexed.vc/api/badge/company/encoded-therapeutics" alt="Encoded Therapeutics on Indexed.vc" width="260" height="76" /></a>